Therapy Areas: Oncology
Flagship Pioneering honours Nancy Simonian with 2019 Pioneering Leader Award
3 December 2019 -

Flagship Pioneering, a company that conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability, has recognised Nancy Simonian, MD, CEO of Syros Pharmaceuticals (NASDAQ: SYRS), with the 2019 Pioneering Leader Award, it was reported yesterday.

Simonian joined Syros Pharmaceuticals as its founding CEO in 2012 and it is claimed that she has led its transformation from a discovery-stage company with a pioneering platform into a publicly traded clinical-stage company with multiple product candidates.

Noubar Afeyan, PhD, founder and CEO of Flagship Pioneering, said, 'Leveraging her successful and distinguished career in bringing new medicines to patients, Nancy has charted the course for Syros, built an impressive team, and positioned the company to deliver new therapies addressing cancer and monogenic diseases. During her tenure at Syros, Nancy has raised capital both privately and in the public markets to support new options for patients and create value for shareholders. In each step of Syros' journey, Nancy has shown pioneering spirit, strong instincts, and true leadership. We congratulate Nancy and look forward to Syros' bright future.'